/

Other

/

Acadia Pharmaceuticals

Acadia Pharmaceuticals

Acadia Pharmaceuticals

Verified Nov 2026

Other

·

United States flag

San Diego, California

·

Since 1993

Acadia Pharmaceuticals is a biopharmaceutical company headquartered in San Diego, California, founded in 1993. With 500-1,000 employees and estimated revenue of $1-5 billion, the company develops treatments for neurological disorders and rare diseases. Its commercial portfolio includes NUPLAZID for Parkinson's disease psychosis and DAYBUE for Rett syndrome, with a pipeline targeting Alzheimer's disease psychosis, Lewy body dementia, and other conditions.

Acadia Pharmaceuticals

Verified Nov 2026

AT A GLANCE

Founded

1993

Headquarters

United States flag

San Diego, California

Employees

500-1,000

Ownership

Acadia Pharmaceuticals at a glance

Revenue

$1-5B

Est. band

Employees

500-1,000

Founded

1993

Headquarters

San Diego, California

Industries

Automotive

Electric Vehicles

Medical

Overview

Acadia Pharmaceuticals is a biopharmaceutical company headquartered in San Diego, California, founded in 1993. With 500-1,000 employees and estimated revenue of $1-5 billion, the company develops treatments for neurological disorders and rare diseases. Its commercial portfolio includes NUPLAZID for Parkinson's disease psychosis and DAYBUE for Rett syndrome, with a pipeline targeting Alzheimer's disease psychosis, Lewy body dementia, and other conditions.

At a glance

Attribute

Detail

Founded

1993

Headquarters

San Diego, California

Employees

500-1,000

Revenue

$1-5B (estimated)

What Acadia Pharmaceuticals makes

Acadia's capabilities span small-molecule central nervous system therapies, FDA-approved drug development, and clinical research focused on underserved neurological and rare disease populations.

Latest developments

Company details

The company collaborates with pharmaceutical partners and serves neurologists, psychiatrists, and long-term care physicians globally. Acadia Pharmaceuticals was founded in 1993, has an estimated 500-1,000 employees, and is headquartered in San Diego, California.

Frequently asked questions

What does Acadia Pharmaceuticals do?

Acadia Pharmaceuticals is a biopharmaceutical company headquartered in San Diego, California, founded in 1993. With 500-1,000 employees and estimated revenue of $1-5 billion, the company develops treatments for neurological disorders and rare diseases. Its commercial portfolio includes NUPLAZID for Parkinson's disease psychosis and DAYBUE for Rett syndrome, with a pipeline targeting Alzheimer's disease psychosis, Lewy body dementia, and other conditions.

Where is Acadia Pharmaceuticals headquartered?

Acadia Pharmaceuticals is headquartered in San Diego, California.

When was Acadia Pharmaceuticals founded?

Acadia Pharmaceuticals was founded in 1993.

How big is Acadia Pharmaceuticals?

Acadia Pharmaceuticals has an estimated 500-1,000 employees, with revenue in the $1-5B range (estimated).

Related suppliers

Explore other suppliers in the LightSource directory:

Last verified Nov 2026. Is this your company? Request a correction.

Location & contact

San Diego, California (HQ)Headquarters · California, United States
San Diego, California (HQ)San Diego, California, United StatesHeadquarters

Evaluating suppliers like these?

This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.